For Merck, this collaboration adds more "chips" to its GLP-1 portfolio and may also serve as a potential successor to Keytrudas market dominance
Day, PharmD, is the Vice President of Clinical Services at PCCA
Globally, it is projected that over 191 million people will be affected by it by 2030, with around 56 million experiencing vision-threatening stages of the disease
Patients should seek immediate medical attention for signs of possible complications such as cellulitis (redness, warmth, fever), deep vein thrombosis (sudden unilateral swelling, calf pain), or significant worsening of symptoms
We consider it complementary it goes deeper into mechanisms that conventional diagnostics are not yet designed to reach